LTRN · Company research
Lantern Pharma Inc. Common Stock (LTRN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A reported Lantern Pharma (LTRN) stake includes 212,554 shares issuable through warrants. - Stock Titan | A reported Lantern Pharma (LTRN) stake includes 212,554 shares issuable through warrants. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History - Yahoo! Finance Canada | Lantern Pharma Inc. (LTRN) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Why Did LTRN Stock Surge 18% In Pre-Market Today? - Stocktwits | Why Did LTRN Stock Surge 18% In Pre-Market Today? Stocktwits | View source ↗ | Stocktwits | Oct 9, 2026 | neutral | 0 | 0.6 |
| With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. - Stock Titan | With 281,597 shares unissued and unreserved, Lantern Pharma (LTRN) proposes a higher share limit. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia | Lantern Pharma Inc. (LTRN) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 1, 2026 | neutral | 0 | 0.6 |
| The stock sale raised about $4 million; share purchases could add roughly $4 million, pending shareholder approval. - Stock Titan | The stock sale raised about $4 million; share purchases could add roughly $4 million, pending shareholder approval. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma (LTRN) Slips 8.48% to $0.99 as Shares Press Toward Key Support - Extension Target - siam.in | Lantern Pharma (LTRN) Slips 8.48% to $0.99 as Shares Press Toward Key Support - Extension Target siam.in | View source ↗ | siam.in | Sep 30, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development - Slideshow (NASDAQ:LTRN) 2026-09-24 - Seeking Alpha | Lantern Pharma Inc. (LTRN) Discusses Open-Medicine AI Platform Roadmap, Business Model, and Value Proposition for Therapeutic Development - Slideshow (NASDAQ:LTRN) 2026-09-24 Seeking Alpha | View source ↗ | Seeking Alpha | Sep 24, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma (NasdaqCM:LTRN) Stock Forecast & Analyst Predictions - Simply Wall Street | Lantern Pharma (NasdaqCM:LTRN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Sep 4, 2026 | neutral | 0 | 0.6 |
| Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation - Simply Wall Street | Here's Why We're A Bit Worried About Lantern Pharma's (NASDAQ:LTRN) Cash Burn Situation Simply Wall Street | View source ↗ | Simply Wall Street | Aug 21, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma Forms Open Medicine AI Subsidiary Business - The Globe and Mail | Lantern Pharma Forms Open Medicine AI Subsidiary Business The Globe and Mail | View source ↗ | The Globe and Mail | Aug 15, 2026 | neutral | 0 | 0.6 |
| $LTRN stock is down 11% today. Here's what we see in our data. - Quiver Quantitative | $LTRN stock is down 11% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 8, 2026 | neutral | 0 | 0.6 |
| LTRN Forecast — Price Target — Prediction for 2027 - TradingView | LTRN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma (LTRN) Shares Promising Phase 2 Trial Results - GuruFocus | Lantern Pharma (LTRN) Shares Promising Phase 2 Trial Results GuruFocus | View source ↗ | GuruFocus | Jun 2, 2026 | neutral | 0 | 0.6 |
| LANTERN PHARMA ($LTRN) Releases Q1 2026 Earnings - Quiver Quantitative | LANTERN PHARMA ($LTRN) Releases Q1 2026 Earnings Quiver Quantitative | View source ↗ | Quiver Quantitative | May 15, 2026 | neutral | 0 | 0.6 |
| Lantern Pharma Stock Drops as Investors Weigh Financial Results and Clinical Pipeline - Timothy Sykes | Lantern Pharma Stock Drops as Investors Weigh Financial Results and Clinical Pipeline Timothy Sykes | View source ↗ | Timothy Sykes | Mar 27, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 14, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.